Comparative Effects of the GABA Uptake Inhibitors, Tiagabine and NNC-711, on Extracellular GABA Levels in the Rat Ventrolateral Thalamus

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 1996 Feb 1

PMID 9182238

Citations 12

Authors

D A Richards

N G Bowery

Affiliations

Soon will be listed here.

Abstract

The primary mechanism by which the action of synaptically released GABA is thought to be terminated is by re-uptake into neurones and glial cells, and the pharmacological inhibition of this uptake may be beneficial in conditions where decreased GABAergic transmission has been implicated, such as epilepsy. We have compared the effects of two of these uptake inhibitors, tiagabine and NNC-711, on extracellular GABA levels in the thalamus of the rat, after both systemic and local administration. Both compounds produced dose-dependent increases in GABA concentration irrespective of the route of administration, but the concentrations required to produce increased extracellular GABA levels were considerably higher than those known to be effective for anticonvulsant purposes. These data suggest that, initially at least, alternative GABA transporters, not susceptible to inhibition by the compounds used, may still be able to remove synaptically released GABA from the extracellular space.

Citing Articles

Expression and functions of glutamate and γ‑aminobutyric acid transporters in ischemic models.

Qian Z, Lin Y, Xing J, Qiu Y, Ren L Mol Med Rep. 2018; 17(6):8196-8202.

PMID: 29693164 PMC: 5984000. DOI: 10.3892/mmr.2018.8888.

Reduction in focal ictal activity following transplantation of MGE interneurons requires expression of the GABAA receptor α4 subunit.

Jaiswal M, Keros S, Zhao M, Inan M, Schwartz T, Anderson S Front Cell Neurosci. 2015; 9:127.

PMID: 25914623 PMC: 4391265. DOI: 10.3389/fncel.2015.00127.

Effects of γ-Aminobutyric acid transporter 1 inhibition by tiagabine on brain glutamate and γ-Aminobutyric acid metabolism in the anesthetized rat In vivo.

Patel A, de Graaf R, Rothman D, Behar K J Neurosci Res. 2015; 93(7):1101-8.

PMID: 25663257 PMC: 4441585. DOI: 10.1002/jnr.23548.

Neuropharmacological and neurobiological relevance of in vivo ¹H-MRS of GABA and glutamate for preclinical drug discovery in mental disorders.

Waschkies C, Bruns A, Muller S, Kapps M, Borroni E, von Kienlin M Neuropsychopharmacology. 2014; 39(10):2331-9.

PMID: 24694923 PMC: 4138741. DOI: 10.1038/npp.2014.79.

Impairment of GABA transporter GAT-1 terminates cortical recurrent network activity via enhanced phasic inhibition.

Razik D, Hawellek D, Antkowiak B, Hentschke H Front Neural Circuits. 2013; 7:141.

PMID: 24062646 PMC: 3769619. DOI: 10.3389/fncir.2013.00141.

References

Krogsgaard-Larsen P, Johnston G . Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds. J Neurochem. 1975; 25(6):797-802. DOI: 10.1111/j.1471-4159.1975.tb04410.x. View

Sayin U, Timmerman W, Westerink B . The significance of extracellular GABA in the substantia nigra of the rat during seizures and anticonvulsant treatments. Brain Res. 1995; 669(1):67-72. DOI: 10.1016/0006-8993(94)01240-i. View

Suzdak P . Lack of tolerance to the anticonvulsant effects of tiagabine following chronic (21 day) treatment. Epilepsy Res. 1994; 19(3):205-13. DOI: 10.1016/0920-1211(94)90063-9. View

Marescaux C, VERGNES M, Depaulis A . Genetic absence epilepsy in rats from Strasbourg--a review. J Neural Transm Suppl. 1992; 35:37-69. DOI: 10.1007/978-3-7091-9206-1_4. View

Fink-Jensen A, Suzdak P, Swedberg M, JUDGE M, Hansen L, Nielsen P . The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats. Eur J Pharmacol. 1992; 220(2-3):197-201. DOI: 10.1016/0014-2999(92)90748-s. View

Nielsen E, Suzdak P, Andersen K, Knutsen L, Sonnewald U, Braestrup C . Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor. Eur J Pharmacol. 1991; 196(3):257-66. DOI: 10.1016/0014-2999(91)90438-v. View

Johnston G, Stephanson A, Twitchin B . Uptake and release of nipecotic acid by rat brain slices. J Neurochem. 1976; 26(1):83-7. View

Larsson O, Falch E, Krogsgaard-Larsen P, Schousboe A . Kinetic characterization of inhibition of gamma-aminobutyric acid uptake into cultured neurons and astrocytes by 4,4-diphenyl-3-butenyl derivatives of nipecotic acid and guvacine. J Neurochem. 1988; 50(3):818-23. DOI: 10.1111/j.1471-4159.1988.tb02986.x. View

Walton N, Gunawan S, Treiman D . Treatment of experimental status epilepticus with the GABA uptake inhibitor, tiagabine. Epilepsy Res. 1994; 19(3):237-44. DOI: 10.1016/0920-1211(94)90067-1. View

10.

Waldmeier P, Stocklin K, Feldtrauer J . Weak effects of local and systemic administration of the GABA uptake inhibitor, SK&F 89976, on extracellular GABA in the rat striatum. Naunyn Schmiedebergs Arch Pharmacol. 1992; 345(5):544-7. DOI: 10.1007/BF00168946. View

11.

Liu Z, VERGNES M, Depaulis A, Marescaux C . Evidence for a critical role of GABAergic transmission within the thalamus in the genesis and control of absence seizures in the rat. Brain Res. 1991; 545(1-2):1-7. DOI: 10.1016/0006-8993(91)91262-y. View

12.

Herrera-Marschitz M, Meana J, OConnor W, Goiny M, Reid M, Ungerstedt U . Neuronal dependence of extracellular dopamine, acetylcholine, glutamate, aspartate and gamma-aminobutyric acid (GABA) measured simultaneously from rat neostriatum using in vivo microdialysis: reciprocal interactions. Amino Acids. 2013; 2(1-2):157-79. DOI: 10.1007/BF00806086. View

13.

Suzdak P, Frederiksen K, Andersen K, Sorensen P, Knutsen L, Nielsen E . NNC-711, a novel potent and selective gamma-aminobutyric acid uptake inhibitor: pharmacological characterization. Eur J Pharmacol. 1992; 224(2-3):189-98. DOI: 10.1016/0014-2999(92)90804-d. View

14.

Biggs C, Pearce B, Fowler L, Whitton P . The effect of sodium valproate on extracellular GABA and other amino acids in the rat ventral hippocampus: an in vivo microdialysis study. Brain Res. 1992; 594(1):138-42. DOI: 10.1016/0006-8993(92)91038-g. View

15.

Westerink B, DE VRIES J . On the origin of extracellular GABA collected by brain microdialysis and assayed by a simplified on-line method. Naunyn Schmiedebergs Arch Pharmacol. 1989; 339(6):603-7. DOI: 10.1007/BF00168650. View

16.

Borden L, Murali Dhar T, Smith K, Weinshank R, Branchek T, Gluchowski C . Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur J Pharmacol. 1994; 269(2):219-24. DOI: 10.1016/0922-4106(94)90089-2. View

17.

Richards D, Lemos T, Whitton P, Bowery N . Extracellular GABA in the ventrolateral thalamus of rats exhibiting spontaneous absence epilepsy: a microdialysis study. J Neurochem. 1995; 65(4):1674-80. DOI: 10.1046/j.1471-4159.1995.65041674.x. View

18.

Smith S, Parvez N, Chapman A, Meldrum B . The gamma-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy. Eur J Pharmacol. 1995; 273(3):259-65. DOI: 10.1016/0014-2999(94)00696-5. View

19.

Braestrup C, Nielsen E, Sonnewald U, Knutsen L, Andersen K, Jansen J . (R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain gamma-aminobutyric acid uptake carrier. J Neurochem. 1990; 54(2):639-47. DOI: 10.1111/j.1471-4159.1990.tb01919.x. View

20.

Coenen A, Blezer E, van Luijtelaar E . Effects of the GABA-uptake inhibitor tiagabine on electroencephalogram, spike-wave discharges and behaviour of rats. Epilepsy Res. 1995; 21(2):89-94. DOI: 10.1016/0920-1211(95)00015-3. View